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Abstract
House dust mite allergens (HDM) cause bronchoconstriction in asthma patients and induce an
inflammatory response in the lungs due to the release of cytokines, chemokines and additional
mediators. The mechanism how HDM components achieve this is largely unknown. The objective
of this study was to assess whether HDM components of Dermatophagoides pteronissinus with
protease activity (Der p 1) and unknown enzymatic activity (Der p 2, Der p 5) induce biological
responses in a human airway-derived epithelial cell line (A549), and if so, to elucidate the underlying
mechanism(s) of action. A549 cells were incubated with HDM extract, Der p 1, recombinant Der
p 2 and recombinant Der p 5. Cell desquamation was assessed by microscopy. The
proinflammatory cytokines, IL-6 and IL-8, were measured by ELISA. Intracellular Ca2+ levels were
assessed in A549 cells and in mouse fibroblasts expressing the human protease activated receptor
(PAR)1, PAR2 or PAR4. HDM extract, Der p 1 and Der p 5 dose-dependently increased the
production of IL-6 and IL-8. Added simultaneously, Der p 1 and Der p 5 further increased the
production of IL-6 and IL-8. The action of Der p 1 was blocked by cysteine-protease inhibitors,
while that of Der p 5 couldn't be blocked by either serine- or cysteine protease inhibitors. Der p
5 only induced cell shrinking, whereas HDM extract and Der p1 also induced cell desquamation.
Der p 2 had no effect on A549 cells. Der p 1's protease activity causes desquamation and induced
the release of IL6 and IL-8 by a mechanism independent of Ca2+ mobilisation and PAR activation.
Der p 5 exerts a protease-independent activation of A549 that involves Ca2+ mobilisation and also
leads to the production of these cytokines. Together, our data indicate that allergens present in
HDM extracts can trigger protease-dependent and protease-independent signalling pathways in
A549 cells.
Background
House dust mite (Dermatophagoides pteronissinus) extracts
contain allergens with potent sensitising capacities in
atopic subjects. The sensitisation to HDM allergens is not
only caused by exposure to allergenic compounds of the
HDM but also by compounds that facilitate the access of
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duced by house dust mites (HDM) and fungi, or proteases
present in pollen are able to decrease the barrier function
of the epithelial cell layer. The proteases may disrupt the
tight-junctions between epithelial cell and lead to the
complete desquamation of the epithelial cell layer, hence
facilitating the passage of allergens across the epithelial
surface [1-3] Extracts of Dermatophagoides pteronissinus and
Lepidoglyphus destructor have been shown to cause epithe-
lial cell desquamation in a protease-dependent way. The
result of the desquamation may be that allergenic com-
pounds penetrate deep into the airway wall.
Airway-derived epithelial cells have been shown to
increase the release of proinflammatory cytokines, such as
interleukin (IL)-6 and IL-8, in response to proteases
present in HDM-, pollen- and fungal extracts [4-7]. The
release of cytokines may be mediated by protease acti-
vated receptors (PAR) that have been found on these cells
[8,9]. Definitive proof for a PAR-mediated mechanism of
these observations is hampered by the lack of specific PAR
antagonists, but the use of human PAR expressed mouse
fibroblast may elucidate whether a PAR is involved in the
protease-dependent cytokine production [5]. In addition
to protease-mediated mechanisms, a protease-independ-
ent activation of epithelial cells has been observed in stud-
ies with HDM extracts [4]. The latter observation
suggested a possible interaction of airway epithelial cells
with non-protease compounds of HDM extracts.
HDM extracts contain many proteins of known and
unknown character, including Der p 1, Der p 2 and Der p
5. Der p1 has been shown to have cysteine protease activ-
ity [10-12] that may cause the observed epithelial cell
desquamation, release of cytokines and facilitate trans-
port of allergens across cultured epithelial cell layers
[2,3,7,13]. Der p 2 and Der p 5 lack a clear-cut protease
activity, but are major IgE binding proteins [14] and of
unknown biological function [15]. In the present study
we further elucidated the mechanism by which HDM
extracts, a purified major allergen Der p 1, and three
recombinant major HDM allergens (recDer p 1, recDer p
2, and recDer p 5) affect the biochemical properties of air-
way derived epithelial cells. We assessed how these com-
pounds changed A549 cell morphology, whether they
induced cell desquamation and their capacity to induce
cytokine production. The mobilization of intracellular
Ca2+ and the involvement of protease activated receptors
was analysed using mouse fibroblasts expressing human
PAR1, PAR2 or PAR4.
Methods
House dust mite extract and (recombinant) allergens
Standardized lyophilized extracts of the house dust mite
(D. pteronissinus) was a gift of Dr. Nico Niemeyer (ALK-
Benelux, The Netherlands). Affinity chromatography puri-
fied natural Der p1 and the recombinant allergens (Der p
1 [16,17], Der p 2 [18], and processed Der p 5 [19]) were
a generous gift of Dr. Martin D. Chapman (Indoor Bio-
technologies Ltd, Cardiff, UK). Total protease (using
casein as a substrate), elastase (using N-succinyl-alanyl-
alanyl-prolyl-leucine p-nitro-anilide as a substrate) and
gelatinase (using gelatin-orange as a substrate) activities
of the mite extract were quantified as previously described
[4].
Epithelial cell lines and cell activation
A549 cells, a human alveolar type II epithelium-like cell
line, were obtained from American Type Culture Collec-
tion (Rockville, MD). The epithelial cells were cultured in
sterile 24-well culture dishes (Costar) in RPMI 1640 con-
taining 5% heat-inactivated foetal calf serum comple-
mented with 0.05% gentamycine to 90% confluency, as
described previously [5]. Before incubation with the HDM
extract or components, the cell cultures were incubated
with serum-free medium during 24 hours (37°C). Stimu-
lation of A 549 cells was performed with various concen-
trations of HDM or compounds there of (Der p1, Der p2
and Der p5) in serum-free medium complemented with
LPS inhibitor colistin (10 µg/ml) at 37°C, 5% CO2. In
order to have fully active purified Der p1 was reduced by
incubating it with 0.5 mmol glutathione for 5 minutes
before it was applied to the cell cultures. Chymostatin (10
µg/ml, Sigma) was used as non-specific protease inhibi-
tor; Phenylmethylsulphonyl fluoride (PMSF, 0.25 mM,
Sigma) was used as specific serine protease inhibitor;
Trans-epoxysuccinyl L-leucylamido (4 guanidine) butane
[E-64 (10 µM, Sigma)] was used as a specific cysteine pro-
tease inhibitor. Prior to addition, the protease inhibitors
were incubated for 15 minutes (37°C) with HDM, Der p
1 and Der p 5 containing medium. Heat-treatment of
media containing HDM extract, Der p 1 and Der p 5 was
done at 65°C for 30 minutes. After 24 hours of incubation
with the HDM components, supernatant was collected
and stored at -20°C. Cytokine production was quantified
using commercially available ELISA-kits for IL-6 (detec-
tion limit 1–3 pg/ml; Sanguin, Amsterdam, The Nether-
lands) and IL-8 (detection limit 4–8 pg/ml; Sanguin). Cell
morphology was assessed by light microscope and quan-
tified on an arbitrary scale (no effect = same morphology
as non-treated cell; shrinking = visual changes in mor-
phology predominated by cell shrinking and partial cell
desquamation (≤10%) but no floating cells; desquama-
tion = >10% cells have detached and are floating around)
[5]. Cell viability was quantified using the trypan blue
exclusion method. The presence of PAR receptors on A549
epithelial cells was checked by incubating the cells for 24
hrs with increasing concentrations of the PAR-1 and PAR-
2 agonists. PAR1 (NH2-S-F-L-L-R-N-C) and PAR-2 agonist
(NH2-S-L-I-G-K-V-C) were obtained from EurosequencePage 2 of 8
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of PAR-1 and PAR-2 were used to show specificity of the
PAR-1 and PAR-2 agonists.
Ca2+ studies
Intracellular Ca2+ measurements were performed on
mouse fibroblasts expressing human PAR1, PAR2 or PAR4
(kindly provided by Dr Patricia Andrade-Gordon) and on
A549 cells as previously described [20]. A549 cells were
detached with protease-free buffer (CDS, Sigma) and
resuspended in Hanks' solution at a concentration of 107
cells/ml. The cells were loaded with 2 mM indo-1/AM for
30 min at room temperature in the dark. Under these con-
ditions, compartmentalization of the dye was minimal as
judged from the ratio of fluorescence signals obtained
after selective permeabilization of the plasma membrane
(10 mM β-escin) and full permeabilization of the cells
(1% Triton X-100). Then the cells were washed twice by
centrifugation and their fluorescence was measured in an
Aminco-Bowman spectrophotometer, using 106 cells/ml.
Measurements were performed at 22°C, with a single exci-
tation wavelength (349 nm) and a dual emission wave-
length (410 and 490 nm) at a frequency of 1 Hz.
Thapsigargin responses were measured at the plateau
phase, which represents capacitative Ca2+ influx. In Ca2+-
free conditions, this plateau was not reached (see also
[20]).
Data analysis
All experiments were performed at least six times. Statisti-
cal analysis was performed with the student t-test. p values
≤ 0.05 were considered significant.
Results
House dust mite extract and Der p 1 induce morphological 
changes and cell desquamation in A549 cultures
As summarized in table I, both HDM extract and purified
natural Der p 1 dose-dependently induced morphological
changes. Low concentrations of these compounds were
associated by cell shrinking, whereas higher concentra-
tions lead to total cell desquamation of confluent A549
cell layers without affecting cell viability (all ≥97%). Both
shrinking and desquamation were reversed by the pro-
tease inhibitors chymostatin (non-specific) and antipain
(serine-proteinase specific inhibitor). Recombinant Der p
5 only caused shrinking of the A549 cells at the highest
concentration (100 µg/ml), and did not induce desqua-
mation of the cells. Recombinant Der p 2 neither affected
cell morphology nor induced desquamation.
HDM extract, natural and recombinant Der p 1, and Der 
p 5 induce cytokine release by A549 cells
As demonstrated in figure 1, HDM extract, purified natu-
ral Der p 1 and recombinant Der p 5 induced a dose-
Table 1: Effects on cell shrinking and desquamation of house dust 
mite (HDM) extract and three recombinant allergens: Der p1, 
Der p2 and Der p5 (in µg/ml).
No Effect Shrinking Desquamation
Der p1 0 – 1 10 100*
Der p5 0 – 10 100 NA
Der p2 1 – 100 NA NA
HDM extract 0 – 1 2 – 10 50 – 400*
* = viability of cells ≥97%; NA = not applicable.
Dose-response of crude house-dust-mite (HDM) extract, natural purified Der p1 and recombinant (r)Der p5 of absolute levels of inte leuki  (IL)-6 (left panel) and IL-8 (right panel) proteinFigure 1
Dose-response of crude house-dust-mite (HDM) extract, natural purified Der p1 and recombinant (r)Der p5 of absolute levels 
of interleukin (IL)-6 (left panel) and IL-8 (right panel) protein. A549 cells were incubated during 24 hours in the absence and 
presence of increasing concentrations (indicated in µg/ml) of HDM extract, Der p1 and recombinant (r)Der p5. IL-6 protein 
levels are expressed as pg/ml; IL-8 protein levels are expressed as ng/ml.
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< 0.05) and IL-8 proteins (n = 5, p < 0.05). The maximum
level of cytokine production was achieved with 10 µg/ml
HDM extract, while higherconcentrations reduced
cytokine levels. Purified natural Der p 1 showed a maxi-
mal production of IL-6 (n = 6, p < 0.05) and IL-8 (n = 6, p
< 0.05) at high concentrations (≥10 µg/ml). Reduction of
natural Der p 1 with glutathione further increased the pro-
duction of IL-6 and IL-8 (approximately 2-fold; data not
shown), whereas the cytokine-inducing capacity of
recombinant Der p 1 was not affected after glutathione
treatment, indication that recombinant Der p 1 was
already in its most active (reduced) form (data not
shown). The recombinant Der p5 was the most potent
inductor of cytokine production in A549 cells, and caused
a dose-dependent and significant increase of both IL-6 (n
= 6, p < 0.05) and IL-8 (n = 6, p < 0.05) with a maximal
production at 100 µg/ml. In contrast, recombinant Der p
2 did not affect cytokine production, at all (data not
shown). As shown in figure 2, the simultaneous addition
of Der p 1 (20 µg/ml) plus Der p5 (20 µg/ml) further
increased the production ofIL-6 (3-fold) and IL-8 (2-fold).
Der p 1- and Der p 5-induced cytokine release are 
protease-dependent and protease-independent, 
respectively
Next, we determined the effects of heat treatment and pro-
tease inhibitors on allergen-induced production of IL-6
and IL-8. Heat treatment completely blocked natural Der
p 1-induced cytokine release, while it only partially
reduced the effect of recombinant Der p5 (IL-6 minus
28%, IL-8 minus 42%). As shown in figure 3, IL-6 and IL-
8 production induced by the purified Der p 1 was com-
pletely inhibited by the cysteine-protease inhibitor E-64
(n = 5, p < 0.05). Chymostatin partially reduced purified
Der p 1-induced cytokine production. In the presence of
E-64, the higher levels of IL-6 and IL8 induced with a Der
p 1 plus Der p5-induced IL-6 and IL-8 levels were dimin-
ished and comparable with levels induced by Der p 5
alone (figure 2).
PAR2 agonist (NH2-S-L-I-G-K-V-C) increased cytokine 
production in A549 cells
Because epithelial cells express protease-activated recep-
tors (PAR), we examined whether a PAR-mediated mech-
anism is involved in HDM and Der p 1 induced cytokine
production. PAR1 or PAR2 agonists were added to A549
cultures. As shown in figure 4, only the PAR2 agonist
Effects of the several protease inhibitors on IL-6 and IL-8 protein secr tion by A549 cellsFigure 3
Effects of the several protease inhibitors on IL-6 and IL-8 
protein secretion by A549 cells. Cells were stimulated during 
24 hours with an optimal concentration of recombinant 
(r)Der p 1 (20 µg/ml), in absence and presence of optimal 
inhibitory concentrations of chymostatin (50 µg/ml; serine-
protease inhibitor), E64 (10 µM; cysteine-protease inhibitor), 
or PMSF (0.25 mM; serine-protease inhibitor), or a combina-
tion of E64 plus PMSF. IL-6 protein levels are expressed as 
pg/ml, whereas IL-8 protein levels are expressed as ng/ml. * p 
< 0.05, significantly enhanced expression compared to 
unstimulated cells (medium); # p < 0.05 significantly dimin-
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Effects of the cysteine protease inhibitor E64 (10 µM) on IL-6 (open bars) and IL-8 (hatched bars) protein secretionFigure 2
Effects of the cysteine protease inhibitor E64 (10 µM) on IL-6 
(open bars) and IL-8 (hatched bars) protein secretion. A549 
cells were stimulated during 24 hours with an optimal con-
centration of recombinant allergens: Der p 1 (20 µg/ml), Der 
p 5 (20 µg/ml) or a combination of Der p1 plus Der p 5. IL-6 
protein levels are expressed as pg/ml, whereas IL-8 protein 
levels are expressed as ng/ml. * p < 0.05, significantly 
enhanced expression compared to negative control 
(medium); # p < 0.05, significantly diminished expression 
compared to Der p 1-induced levels; $ p < 0.05, significantly 
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tein and reached a maximal production at 5.10-4 M, indi-
cating the functional presence PAR2 receptors on A549
epithelial cells. Neither the retrograde analogue of PAR2
nor the retrograde analogue of PAR1 did affect IL-6 or IL-
8 production, indicating the specificity of the PAR2 ago-
nist.
Der p 5 mobilises intracellular free Ca2+ by a PAR-
independent mechanism
The data obtained with the former experiments suggested
that a functional PAR2 is expressed on A549 cells. It has
been demonstrated that PAR activation leads to the mobi-
lization of intracellular free [Ca2+], and, to further eluci-
date the underlying mechanism triggered by HDM, Der p
1 and Der p 5, we measured intracellular Ca2+ levels in
A549 cells treated in absence and presence of these com-
pounds. As shown in figure 5, only Der p 5 was able to sig-
nificantly mobilise [Ca2+]i. Finally, we assessed whether
cytokine production induced by HDM, Der p 1 and Der p
5 is mediated via the activation of protease activated
receptors (PAR). To this end we used mouse fibroblasts
expressing the human PAR1, PAR2 or PAR4 and [Ca2+]i
was measured. As expected, the PAR agonists trypsine
(specific for PAR2) and thrombine (for PAR1 and PAR4)
dose-dependently induce the mobilisation of [Ca2+]i,
demonstrating the functional presence of the human pro-
tease activated receptors on the mouse fibroblast. In con-
trast, concentrations of HDM, Der p 1 and Der p 5 (10–20
µg/ml) that induced cytokine release in our previous
experiments did not affect [Ca2+]i in these cells (data not
shown).
Discussion
Epithelial cells are important participants in the innate
recognition of foreign substances. Aside from their
mechanical barrier function, epithelial cells may also
express surface receptors that are able to recognise compo-
nents released from house dust mites. Here we show that
airway epithelial cells interact with protease- and non-
protease components from house-dust mites resulting in
IL-6 and IL-8 release. In contrast to the purified and
recombinant allergens, HDM extracts reached a maxi-
mum of activity (around 10 µg/ml), which is followed by
a decline at higher concentrations. This bell-shaped dose-
response profile that has also been observed for fungal
extracts [5] suggests the presence of several activating
components in the HDM extract, including cysteine- and
serine proteases and Der p 5, that synergistically interact
with the A549 cells. At very high concentrations the
cytokine production was abrogated through an unknown
mechanism, but coincided with total epithelial cell desq-
uamation. Der p 1 has been shown to diminish the epi-
thelial integrity through the destruction of the junctional
proteins, in particular occludin and ZO-1 [2,21]. Der p 1-
mediated break-down of these molecules may therefore
explain the observed cell shrinking and desquamation in
our studies.
[Ca2+]i measurements in 106 A549 cellsFigure 5
[Ca2+]i measurements in 106 A549 cells. 5 × 107 A549 cells 
were loaded with 2 µM indo-1/AM (see Materials and Meth-
ods), followed by washing and dual-wavelength measurement 
of fluorescence, using 106 cells/ml per measurement. [Ca2+]i 
was calculated as described. The three traces presented are 
representative for three independent experiments and show 
the effects of House dust mite extract (HDM), recombinant 
Der p 1 and recombinant Der p 5 on intracellular Ca2+ 
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Effects of agonists for protease activated receptor (PAR)1 and PAR2Figure 4
Effects of agonists for protease activated receptor (PAR)1 
and PAR2. The agonists used for PAR-1 and PAR-2 are NH2-
S-F-L-L-R-N-C and NH2-S-L-I-G-K-V-C, respectively. In the 
experiment shown the concentration of both PAR1 and 
PAR2 was 0.5 mM. IL-1β is shown as a positive control. * p < 
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inhibitor E-64 blocked cell shrinking and desquamation,
as well as the release of IL-6 and IL-8. The less specific pro-
tease inhibitor chymostatin also inhibited cell shrinking
and desquamation as well as the production of cytokines.
The latter finding is in agreement with observations that
Der p1 has been shown to contain both cysteine and ser-
ine activity [12]. This dual cysteine-serine proteinase activ-
ity of Der p 1 has been a matter of debate, since the serine
proteinase inhibitor 4-(2-aminoethyl)-benzenesulphonyl
fluoride hydrochloride (AEBSF) did not affect Der p1
induced changes in permeability of epithelial monolayers
[21]. In our present study the serine protease inhibitor
reversed the Der p 1-induced effects in the presence of glu-
tathione and suggested that Der p 1 has to be in its
reduced state to provide functional serine-protease activ-
ity. The structurally very similar (recombinant) Der f 1 is
strongly inhibited by the cysteine protease inhibitor E64
[22] and suggests that access to the active site of Der p 1 is
hampered through steric hindrance and/or electrostatic
interaction of substrates, thus preventing sufficient access
to the enzymatic cleft. Recent three-dimensional space-
filling studies of the Der p 1 molecule indicate that Der p
1 is not a serine protease, however [23]. Alternatively, the
observed discrepancy between different studies might be
due to the purity of the extracts used.
Our observation that Der p 1 activated the A549 epithelial
cells to produce cytokines is consistent with the observa-
tion that proteases from house dust mites and fungal ori-
gin are able to activate NF-κB, a transcription factor
critical for the production of IL-6 and IL-8 by epithelial
cells [6]. Studies of protease-induced signalling, especially
in platelets, endothelial cells and keratinocytes, have
shown an abundance of G-coupled signalling pathways
that are triggered upon cleavage of Protease-activated
receptors (PARs) [24] PARs are also present on epithelial
cells [8,9], including A549 cells [25,26], and the effect of
Der p 1 may thus be mediated through cleavage of PARs,
as has been reported for Der p 3 and Der p 9 [26]. Some
conflicting reports have emerged in the literature regard-
ing Der p 1 and PAR activation [27-29]. We demonstrated
that a functional PAR2 is present on A549 cells by the spe-
cific PAR2 agonists, which induced the production of IL-6
and IL-8 in our studies. However, the mouse fibroblasts
expressing the human PAR1, PAR2 or PAR4 demonstrated
that the HDM extract, Der p 1 and Der p 5 did not affect
intracellular calcium mobilization in these cells, and
would rather argue against a PAR-mediated mechanism.
That Der p 1 activates the release of cytokines from A549
cells in a PAR-independent manner is in accord with a
recent study, showing that Der p 3 but not Der p 1 acti-
vated the PAR2 signalling cascade, hence inducing IL-8
[28]. An explanation for the conflicting reports would be
contaminations of purified Der p 1 with Der p 3 as has
also been suggested by Takai et al [29], and suggests that
the Der p 1 used in our present studies is of high quality.
To completely exclude a PAR2-mediated mechanism
would require specific PAR2 antagonists, but those are
currently not available.
The recombinant Der p 5 also induced the secretion of IL-
6 and IL-8, and to an even higher extent than Der p 1. This
effect of Der p 5 was dose-dependent, could not be
blocked by protease inhibitors, and was specific, since
recombinant Der p 2, another major HDM allergen, did
not have any effect on the production of these cytokines.
The combination of both Der p 1 and Der p 5 had an addi-
tive effect on IL-8 production and a synergistic effect on
IL-6 production, demonstrating that Der p 5 activates a
distinctly different intracellular signalling pathway than
Der p 1. Der p 5 is of unknown biological functional [17],
and the signalling pathways triggered by the Der p 5 have
not been studies thus far. Here we showed that at least a
calcium-dependent pathway might be activated by recom-
binant Der p 5. It may be hypothesised that receptors
from innate recognition system, e.g. the Toll-like recep-
tors, may be involved. If so, the synergistic interaction
may be expected at the level of the activation of NF-κB
[30,31] The HDM extract itself did not increase intracellu-
lar calcium levels, probably because the concentrations of
Der p 5 and/or Der p3 in the HDM extract are insufficient
to elicit this response.
In accordance with previous findings, we showed that the
HDM-derived protease Der p 1 caused both damage and
activation of airway epithelial cells. Damage to epithelial
cells may facilitate the passage of allergens over the
mucosal membrane, whereas an increased release of
cytokines may induce an inflammatory response in the
airway tissue. Whether the synergistic effect of Der p 1
plus Der p 5 causes results in the allergen to deeper pene-
trate into the airway wall, and enhances the immune
response remains to be elucidated, but our observations
may certainly contribute to non-allergic inflammatory
responses in the airways.
Conclusion
Allergens present in HDM extracts activate airway-derived
epithelial cells in at least two ways: protease-dependent
and protease-independent. Protease-dependent activation
results in morphological changes, cell-desquamation and
production of proinflammatory cytokines. Protease-inde-
pendent activation further boosts production of proin-
flammatory cytokines, without affecting cell morphology.
These two mechanisms may act synergistically, aggravat-
ing the ongoing inflammatory response observed in asth-
matic airways. If we learn how to counteract these
unexpected biological activities of allergens we might bePage 6 of 8
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patients.
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